Systemic Adjuvant Treatment of T1a and T1b NOMO HER2+Breast Carcinomas; an AERIO/UNICANCER Study.

被引：0
|
作者：
Peron, J. [1 ]
Vano, Y. [1 ]
Frenel, J-S [1 ]
Wassermann, J. [1 ]
Albiges, L. [1 ]
Rodrigues, M. J. [1 ]
Cottu, P. H. [1 ]
机构：
[1] Ctr Leon Berard, F-69373 Lyon, France
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P2-18-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-18-03
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic comparison of T1a and T1b glottic carcinomas
    Kessing, Richard
    LARYNGO-RHINO-OTOLOGIE, 2023, 102 (12) : 903 - 904
  • [2] The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+breast cancer.
    Johnson, Kai Conrad Cecil
    Ni, Ai
    Grimm, Michael
    Sardesai, Sagar D.
    Stover, Daniel G.
    Cherian, Mathew Amprayil
    Gatti-Mays, Margaret Elena
    Pariser, Ashley
    Sudheendra, Preeti Khetarpal
    Williams, Nicole Olivia
    VanDeusen, Jeffrey Bryan
    Ramaswamy, Bhuvaneswari
    Wesolowski, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Commentary on "Prognostic comparison of T1a and T1b glottic carcinomas"
    Hummel, Jens
    LARYNGO-RHINO-OTOLOGIE, 2023, 102 (12) : 904 - 904
  • [4] Treatment of small (T1mic, T1a, and T1b) node-negative HER2+breast cancer - a review of current evidence for and against the use of anti-HER2 treatment regimens
    Johnson, Kai C. C.
    Quiroga, Dionisia
    Sudheendra, Preeti
    Wesolowski, Robert
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (05) : 505 - 522
  • [5] Small Invasive Carcinomas of the Breast (T1a, T1b): The Importance of an Extended Follow Up
    Loureiro, J.
    Monteiro, P.
    Castro, C.
    Bento, M. J.
    Leal, C.
    LABORATORY INVESTIGATION, 2013, 93 : 55A - 55A
  • [6] Small Invasive Carcinomas of the Breast (T1a, T1b): The Importance of an Extended Follow Up
    Loureiro, J.
    Monteiro, P.
    Castro, C.
    Bento, M. J.
    Leal, C.
    MODERN PATHOLOGY, 2013, 26 : 55A - 55A
  • [7] Utilization of adjuvant trastuzumab for T1a,b N0 HER2+breast cancer in Ontario.
    Eisen, Andrea
    Yeung, Lyndee
    Gavura, Scott
    Brown, Zachary M.
    Trudeau, Maureen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Axillary lymph node dissection in T1a and T1b breast cancer
    Fancellu, A
    Cottu, P
    Porcu, A
    Castiglia, P
    Lorettu, A
    Mura, I
    Giuliani, G
    Contini, AM
    Dettori, G
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S106 - S106
  • [9] T1a and T1b breast cancer: A twelve-year experience
    Visser, TJ
    Haan, M
    Keidan, R
    Lucas, R
    Ingold, J
    Glover, J
    Riggo, P
    AMERICAN SURGEON, 1997, 63 (07) : 621 - 626
  • [10] Adjuvant chemotherapy outcomes of node negative, T1a, T1b, T1c hormone receptor-negative HER2-positive breast cancer patients
    Paul, Anu
    Shi, Runhua
    Peddi, Prakash
    Burton, Gary
    CANCER RESEARCH, 2017, 77
12345